Early detection matters
- CHD can lead to fibrosis, liver cancer, and death.8
- 70% to 80% of people with CHD develop cirrhosis within 5 to 10 years vs slower disease progression with HBV monoinfection.9,10
Your patients with hepatitis B virus (HBV)
may be living with hepatitis delta virus (HDV).1
All patients who are positive for
should be
tested for HDV2–4
New treatment options are available.5
HDV reflex testing in all HBsAg+ patients resulted in
5
X
increase in HDV
diagnoses
vs risk-based care6
HDV requires HBV to infect and replicate
Chronic hepatitis delta (CHD) is the most aggressive form of viral hepatitis.
In the United States,
1 in 20
patients with HBV
test positive for HDV1
The American Gastroenterological Association (AGA) and the Chronic Liver Disease Foundation (CLDF) both recommend universal HDV screening for all patients who test positive for HBsAg.12,13
Test all patients who are HBsAg+ at least once.2
Retest patients with risk factors annually.2
Consider retesting when clinically indicated, including unexplained ALT flares or rapidly progressing liver disease.2
Double reflex testing is available for patients being evaluated for HBV. Patients who are HBsAg+ are double reflexed for HDV, using the same specimen. Double reflex testing is available at LabCorp and ARUP.19,20
This resource outlines identification and testing, including laboratory billing codes
View the brochureThe Hepatitis B Foundation offers HDV resources, including facts and figures, additional details on testing, and information for patients at Hepatitis Delta Connect.